The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter. Since the last review it its composite score rose.
CPI Card Group Inc
PMTS · NASDAQ · USD · Market cap $219M · 1,700 employees
CPI Card Group Inc., together with its subsidiaries, provides physical and digital payment solutions for financial institutions, processors, fintechs, prepaid program managers, and other organizations in the United States.
FAIL · Does not pass the screenPrice as of 17 Nov 2026Daily close, not a live quote
Screened 2026-11-17 · the tape above runs as of 06:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price25.86 USD at the 17 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 17 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed17 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $30.00 to $49.86, base estimate $30.00 (screen dated 2026-11-17).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
CPI Card Group Inc holds its Markup at $25.86. Consolidating, no directional conviction, held for 1 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $25.86 |
| Valuation | 23.67 trailing · 7.11 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.06 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Credit Services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Credit Services | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
CPI Card does not clear the screen at the business-activity stage. It operates in an area the screen excludes: Credit Services, so the financial ratios are not the deciding factor here.
Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PMTS's ethical verdict changes
Today PMTS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 17 Nov 2026: it trades at roughly a 14% discount to our $30.00 fair value, none competitive moat, 19.80% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. A 13.8% discount to the base estimate.
Third-party analyst targets. The average target sits +6% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $30.00, with a range of $30.00 to $49.86, dated to the 2026-11-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 20%-growth business trading at just 7.1x forward earnings, with a none competitive moat. That is a 14% discount to our $30.00 fair value: the market is pricing it cautiously while the fundamentals argue otherwise.
| Forward P/E | 7.1xcheap for a company growing this fast |
| Trailing P/E | 23.7xa premium valuation |
| EPS, trailing | 1.02 |
| EPS, forward | 3.40 |
| Revenue growth | +19.8%steady growth |
| Profit margin | 2.2%barely profitable |
| Beta | 1.06moves a little more than the market |
| 52-week range | 10.81 - 25.50 |
| Moat | NONE |
| Market cap | $219M |
| Employees | 1,700 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePMTS trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 7.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 49% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter. Since the last review it its composite score rose.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 49% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 26.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter. Since the last review it its composite score eased.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Parallel49 Equity, Ulc | 10% | S - Sale | 2,687,921 | $54,900,786 |
| 2026-09-14 | Tricor Pmt25 Holdings Inc. | 10% | P - Purchase | 525,000 | $11,287,500 |
| 2026-09-14 | Riley H Sanford | Non-Executive Chairman | P - Purchase | 13,953 | $299,990 |
| 2026-09-14 | Mallela Ravi | Dir | P - Purchase | 1,000 | $21,500 |
| 2026-09-14 | Peters Nicholas | Dir | P - Purchase | 11,628 | $250,002 |
| 2026-09-14 | Sheinbaum Marc | Dir | P - Purchase | 4,651 | $99,997 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.29 | +20.8% | · | $1,208 | +20.8% |
| 2 months | $17.43 | +6.0% | · | $1,060 | +6.0% |
| 3 months | $15.47 | +19.4% | · | $1,194 | +19.4% |
| 6 months | $17.99 | +2.7% | · | $1,027 | +2.7% |
| 1 year | $21.93 | -15.8% | · | $842 | -15.8% |
| 2 years | $27.13 | -31.9% | · | $681 | -31.9% |
| 3 years | $23.03 | -19.8% | · | $802 | -19.8% |
| 5 years | $19.00 | -2.8% | · | $972 | -2.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PMTS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.